Business Context and Reporting Period
MacroGenics, Inc. (MGNX) filed a Form 8-K on December 14, 2022, reporting the entry into a material definitive agreement. The company is incorporated in Delaware and its principal executive offices are located in Rockville, Maryland.
Key Financial Metrics
This filing does not report revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on a lease amendment.
Material Changes
The company entered into a Fifth Amendment to its lease for 122,600 square feet at 9704 Medical Center Drive, Rockville, Maryland. Key changes include:
- Term Extension: The lease term was extended from August 15, 2027, to December 31, 2035.
- Rent Structure: Base rent begins at $46.37 per square foot, escalating annually by 3%.
- Extension Options: Two options to extend the lease term to December 31, 2045.
- Rent Abatement: A 50% abatement on base rent is granted for 24 months starting from the execution date.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future performance. The primary contingency noted is the potential for earlier termination or extension of the lease term beyond the modified period.
Investor Verification Checklist
- Verify the total square footage (122,600 sq ft) and location of the leased premises.
- Confirm the start date and duration of the 50% rent abatement period.
- Review the full text of the Fifth Amendment and original lease, which are intended to be filed as exhibits to the 2022 Form 10-K.
- Assess the impact of the extended lease term and rent escalation on future operating expenses.